5ETK
E. coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase complexed with AMPCPP and inhibitor at 1.09 angstrom resolution
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-02-07 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9707 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 35.790, 57.690, 38.450 |
Unit cell angles | 90.00, 115.57, 90.00 |
Refinement procedure
Resolution | 34.680 - 1.090 |
R-factor | 0.11672 |
Rwork | 0.116 |
R-free | 0.13640 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1q0n |
RMSD bond length | 0.028 |
RMSD bond angle | 1.983 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0103) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 34.680 | 1.110 |
High resolution limit [Å] | 1.090 | 1.090 |
Rmerge | 0.073 | 0.563 |
Number of reflections | 57389 | |
<I/σ(I)> | 14 | 3.1 |
Completeness [%] | 97.7 | 95 |
Redundancy | 7.2 | 6.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.55 | 293 | Protein 6.6 mg/mL, 1 mM AMPCPP, 1 mM inhibitor, 2 mM magnesium chloride, 22 %w/v PEG4000, 0.1 M sodium HEPES, 0.16 M CaCl2 |